Mirum Pharmaceuticals, Inc. Profile Avatar - Palmy Investing

Mirum Pharmaceuticals, Inc.

Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for th…

Biotechnology
US, Foster City [HQ]
Growth Rates · Payout · Yield

Dividends Over Time

  • Records
  • Forecasts [Soon]
Growth Rates
% YoY
% 3Yr
% 5Yr
% 10Yr
Key Metrics
- -% TTM Yield
- - Average Days Gap
Series
% - - Yield
% Payout Ratio
Download
Cash Amount Pay Date
Download
Cash Amount Pay Date
End of MIRM's Analysis
CIK: 1759425 CUSIP: 604749101 ISIN: US6047491013 LEI: - UEI: -
Secondary Listings
MIRM has no secondary listings inside our databases.